Trend: 9 in 10 people who menstruate experience stress or anxiety in the workplace due to their period; 23 productive days lost every year as a result of menstrual-related presenteeism and absenteeism. Additionally, there are well noted trends in growth of the FemTech industry, with projections of $14.67B by 2029, growing at a CAGR of 14.42% from 2024 to 2029, and the rising focus on workplace well-being, especially regarding menstrual health.
Investors' Bets: Cycle-related symptoms are still a real struggle for hundreds of millions. To tackle this, Paris-based Essence, introduced an app which elevates the performance of female employees by optimizing their schedule according to their hormonal cycle. The startup has raised over €500K (angel). The Essence App leverages science and AI to enhance the performance and well-being of women in the workforce by up to 33% by optimizing schedules, fitness routines, and diets according to each phase of their hormonal cycle.
An interesting thing is its subscription-based B2B approach. Instead of selling the app to each user, they sell it to one company (customer). The app aims to achieve an ARR of $1M within the next 18 months.
To-Do: FemTech for menstrual health and well-being at work might be an attractive niche for your app. Half of the world’s population are potential users for such apps. And there are many companies that may be eager to provide tailored support to employees who menstruate.
If you're unsure where to start, visit an incubator's page. If you already have a project and need funding for your startup, click here for more details.
Thanks for reading
Please donate to support founderSnack. It helps the author to access paid data sources.
👍 Do you like this Newsletter?
Share it with friends. Got any questions? Leave a comment.
❤️ Upgrade to support
Your paid subscription (less than two cups of coffee) helps me to access key resources and trends to deliver more insightful ideas to you.
💬 Share your feedback
Please share your feedback. Any opinion and ideas are welcome.